Clinical use of cabergoline as primary and adjunctive treatment for acromegaly

European Journal of Endocrinology
V MoyesW M Drake

Abstract

Cabergoline is a dopamine agonist that may be used as primary or adjunctive therapy for acromegaly. Although one study suggested biochemical control may be achieved in a substantial proportion of patients, it is still commonly perceived to be a relatively ineffective treatment. A prospective audit was performed of 15 consecutive acromegalic patients (eight males, seven females, median age 55, range 31-92 at presentation) treated with cabergoline to determine the effective dose and tolerability. All had normal anterior pituitary function; two patients had hyperprolactinaemia. Magnetic resonance imaging revealed nine adenomata, two partially empty sellae and four structurally normal pituitary glands. Nine patients had undergone transsphenoidal surgery 1-12 months, and one patient had received pituitary radiotherapy 18 years, prior to commencement of cabergoline. All patients had biochemical GH excess; median serum IGF1 471 ng/ml, range 239-746 ng/ml. The calculated mean of a series of GH measurements ranged from 2.7-45.8 mIU/l, median 9.7 mIU/l. On a median weekly dose of cabergoline of 1.75 mg (range 0.5-7 mg) normalisation of both IGF1 and GH occurred in 4 out of the 15 patients (27%). Out of the 15 patients (33%), 5 achieved a...Continue Reading

Citations

Mar 8, 2012·Pituitary·I BernabeuM Marazuela
Oct 5, 2010·Neurosurgical Focus·Maria FleseriuDavid M Cook
Oct 5, 2010·Neurosurgical Focus·Sunil ManjilaWarren R Selman
Feb 8, 2014·Endocrine·Leandro KasukiMônica R Gadelha
Feb 18, 2014·Endocrine·Mónica MarazuelaIgnacio Bernabeu
Jan 10, 2014·Expert Opinion on Emerging Drugs·Sylvère Störmann, Jochen Schopohl
Oct 6, 2015·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Michael H Shanik
Aug 27, 2015·Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición·Eider Pascual-CorralesJuan Carlos Galofré
May 1, 2015·International Journal of Endocrinology and Metabolism·Erick MendozaLeilani Mercado-Asis
Mar 4, 2015·Endocrinology and Metabolism Clinics of North America·Renata S AuriemmaAnnamaria Colao
Oct 22, 2016·Journal of Endocrinological Investigation·T ApaydinP Kadioglu
Mar 31, 2011·Nature Reviews. Endocrinology·Mark SherlockMichael C Sheppard
Jan 18, 2018·European Journal of Endocrinology·Leandro KasukiMônica R Gadelha
Sep 22, 2017·Endocrine Journal·Seo Young LeeChan Soo Shin
May 27, 2010·Current Opinion in Endocrinology, Diabetes, and Obesity·Miguel Debono, John Newell-Price
Sep 9, 2010·The Journal of Clinical Endocrinology and Metabolism·Laurence Katznelson
Feb 18, 2011·The Journal of Clinical Endocrinology and Metabolism·Laure SandretPhilippe Chanson
Aug 24, 2011·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Laurence KatznelsonUNKNOWN American Association of Clinical Endocrinologists
Dec 28, 2016·Pituitary·Emmanuelle Kuhn, Philippe Chanson
Jul 1, 2010·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.